Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC

Public

Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC

N

Shared by NobleBlocks on Jul 13, 2023 • 12:00 AM UTC

Authors:

Masahiro Tsuboi

,

Roy S. Herbst

,

Thomas John

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Jul 13, 2023 • 12:00 AM UTC

NobleID:w1/20260526/AFC06E1A

DOI:10.1056/nejmoa2304594

No figures available

Generate Podcast

Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC | NobleBlocks